Place of Care Trajectories in the Last Two Weeks of Life: A Population-Based Cohort Study of Ontario Decedents

Journal of Palliative Medicine
Danial QureshiHsien Seow

Abstract

Place of death is a commonly reported indicator of palliative care quality, but does not provide details of service utilization near end of life. This study aims to explore place of care trajectories in the last two weeks of life in a general population and by disease cohorts. A retrospective population-based cohort study using linked administrative-health data to examine Ontario decedents between April 1, 2010 and December 31, 2012. Place of care trajectories in the last two weeks of life. We identified 235,159 decedents. Of which, 215,533 represented the major cohorts of our analysis-cancer (32%), frailty (29%), and organ failure (31%). Sixty-one percent of all decedents died in hospital-based settings. Place of care utilization trends show us a marked increase in use of palliative-acute hospital care (13%-26%) and acute hospital care (12%-25%) and a small decrease in community care use (15%-12%) in the last two weeks of life. Those with cancer were the largest users of palliative-acute hospital care, while those with organ failure were the largest users of acute-hospital care. Place of care trajectories show a marked rise in care in hospital-based settings from 29% to 61% in the last two weeks of life. Nearly half of all hos...Continue Reading

References

Mar 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Craig C EarleSusan Block
May 15, 2003·JAMA : the Journal of the American Medical Association·June R LunneyJack M Guralnik
Jan 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Craig C EarleJane C Weeks
Apr 30, 2005·BMJ : British Medical Journal·Scott A MurrayAziz Sheikh
Sep 1, 2005·Journal of Palliative Medicine·Michele SollowayMadeline Gerken
Feb 10, 2006·BMJ : British Medical Journal·Barbara Gomes, Irene J Higginson
Aug 1, 2006·Palliative Medicine·L K Rosenwax, B A McNamara
Nov 14, 2006·Health Policy·Eva JakobssonFannie Gaston-Johansson
Aug 9, 2007·Medical Care Research and Review : MCRR·Andrea GruneirJason Roy
Aug 22, 2008·Palliative Medicine·J CohenL Deliens
Jul 21, 2009·Journal of Pain and Symptom Management·Konrad FassbenderBarry A Finegan
Mar 31, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joachim CohenLuc Deliens
Apr 2, 2010·The New England Journal of Medicine·Thomas M GillHeather G Allore
Jun 29, 2010·Journal of Pain and Symptom Management·Siew Tzuh TangShiao-Chi Wu
Feb 22, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B GomesUNKNOWN PRISMA
Feb 7, 2013·JAMA : the Journal of the American Medical Association·Joan M TenoVincent Mor
Feb 19, 2013·BMC Palliative Care·Barbara GomesIrene J Higginson
Oct 22, 2015·Journal of Palliative Medicine·Hsien SeowRobin Fainsinger
Jan 20, 2016·JAMA : the Journal of the American Medical Association·Justin E BekelmanUNKNOWN International Consortium for End-of-Life Research (ICELR)
Jun 19, 2016·Palliative Medicine·Peter TanuseputroWalter P Wodchis
Apr 26, 2017·Palliative Medicine·Peter Tanuseputro
Aug 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B GomesUNKNOWN PRISMA

❮ Previous
Next ❯

Citations

Feb 6, 2020·Journal of Palliative Medicine·Hsien SeowPeter Tanuseputro
Feb 20, 2020·Journal of the American Heart Association·Kieran L QuinnPeter Tanuseputro
Jul 16, 2020·Journal of Intensive Care Medicine·Ariel HendinKwadwo Kyeremanteng
Jun 15, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Mary-Joanne VerhoefYvette van der Linden
Oct 17, 2019·Deutsches Ärzteblatt International·Carolin Fleischmann-StruzekChristiane S Hartog
May 25, 2021·The American Journal of Hospice & Palliative Care·Anna ParackalJean-Eric Tarride
Aug 25, 2021·The American Journal of Hospice & Palliative Care·Maria Elena Iriarte MonchoTeresa Soria-Comes

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.